Cargando…
Genotype-phenotype correlations in FSHD
BACKGROUND: Facial-scapular-humeral myodystrophy Landouzy-Dejerine (FSHD) is an autosomal dominant disease, the basis of its pathogenesis is ectopic expression of the transcription factor DUX4 in skeletal muscle. There are two types of the disease: FSHD1 (MIM:158900) and FSHD2 (MIM: 158901), which h...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416831/ https://www.ncbi.nlm.nih.gov/pubmed/30871534 http://dx.doi.org/10.1186/s12920-019-0488-5 |
_version_ | 1783403437861371904 |
---|---|
author | Zernov, Nikolay Skoblov, Mikhail |
author_facet | Zernov, Nikolay Skoblov, Mikhail |
author_sort | Zernov, Nikolay |
collection | PubMed |
description | BACKGROUND: Facial-scapular-humeral myodystrophy Landouzy-Dejerine (FSHD) is an autosomal dominant disease, the basis of its pathogenesis is ectopic expression of the transcription factor DUX4 in skeletal muscle. There are two types of the disease: FSHD1 (MIM:158900) and FSHD2 (MIM: 158901), which have different genetic causes but are phenotypically indistinguishable. In FSHD1, partial deletion of the D4Z4 repeats on the 4th chromosome affects the expression of DUX4, whereas FSHD2 is caused by the mutations in the protein regulating the methylation status of chromatin - SMCHD1. High variability of clinical picture, both intra - and inter-family indicates a large number of factors influencing clinical picture. There are key genetic, epigenetic and gender factors that influence the expressivity and penetrance of the disease. Using only one of these factors allows just a rough prediction of the course of the disease, which indicates the combined effect of all of the factors on the DUX4 expression and on the clinical picture. RESULTS: In this paper, we analyzed the impact of genetic, epigenetic and gender differences on phenotype and the possibility of using them for disease prognosis and family counselling. CONCLUSIONS: Key pathogenesis factors have been identified for FSHD. However, the pronounced intra - and inter-family polymorphism of manifestations indicates a large number of modifiers of the pathological process, many of which remain unknown. |
format | Online Article Text |
id | pubmed-6416831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64168312019-03-25 Genotype-phenotype correlations in FSHD Zernov, Nikolay Skoblov, Mikhail BMC Med Genomics Review BACKGROUND: Facial-scapular-humeral myodystrophy Landouzy-Dejerine (FSHD) is an autosomal dominant disease, the basis of its pathogenesis is ectopic expression of the transcription factor DUX4 in skeletal muscle. There are two types of the disease: FSHD1 (MIM:158900) and FSHD2 (MIM: 158901), which have different genetic causes but are phenotypically indistinguishable. In FSHD1, partial deletion of the D4Z4 repeats on the 4th chromosome affects the expression of DUX4, whereas FSHD2 is caused by the mutations in the protein regulating the methylation status of chromatin - SMCHD1. High variability of clinical picture, both intra - and inter-family indicates a large number of factors influencing clinical picture. There are key genetic, epigenetic and gender factors that influence the expressivity and penetrance of the disease. Using only one of these factors allows just a rough prediction of the course of the disease, which indicates the combined effect of all of the factors on the DUX4 expression and on the clinical picture. RESULTS: In this paper, we analyzed the impact of genetic, epigenetic and gender differences on phenotype and the possibility of using them for disease prognosis and family counselling. CONCLUSIONS: Key pathogenesis factors have been identified for FSHD. However, the pronounced intra - and inter-family polymorphism of manifestations indicates a large number of modifiers of the pathological process, many of which remain unknown. BioMed Central 2019-03-13 /pmc/articles/PMC6416831/ /pubmed/30871534 http://dx.doi.org/10.1186/s12920-019-0488-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Zernov, Nikolay Skoblov, Mikhail Genotype-phenotype correlations in FSHD |
title | Genotype-phenotype correlations in FSHD |
title_full | Genotype-phenotype correlations in FSHD |
title_fullStr | Genotype-phenotype correlations in FSHD |
title_full_unstemmed | Genotype-phenotype correlations in FSHD |
title_short | Genotype-phenotype correlations in FSHD |
title_sort | genotype-phenotype correlations in fshd |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416831/ https://www.ncbi.nlm.nih.gov/pubmed/30871534 http://dx.doi.org/10.1186/s12920-019-0488-5 |
work_keys_str_mv | AT zernovnikolay genotypephenotypecorrelationsinfshd AT skoblovmikhail genotypephenotypecorrelationsinfshd |